Tetrahexyldecyl ascorbate is described across medical-grade skincare as the stable form of vitamin C. Under singlet oxygen it degraded completely in six minutes with no co-antioxidant present, and only 25 % degraded in ten minutes when one was. Stability is therefore a property of the finished formulation, not of the molecule.
Published 19 September 2026 · Last reviewed 19 September 2026
What the study measured
The work is Swindell and colleagues, published in 2021 in the International Journal of Molecular Sciences. It exposed tetrahexyldecyl ascorbate — THDC — to singlet oxygen, a reactive oxygen species, and tracked how much survived.
Two numbers are reported, and they are the two numbers on the chart below. "In the absence of AZ, THDC degraded completely by 6 min." With acetyl zingerone present as a co-antioxidant, "there was only a 25% degradation of THDC after 10 min."
The same paper reports two further results that matter more than they first appear. THDC on its own did not significantly change collagen I levels; the increase came from the co-antioxidant, and from the combination. And THDC alone "led to up-regulation of type I interferon genes" in reconstructed human epidermis — an inflammatory signature that disappeared when the co-antioxidant was present. Its measured oxygen radical absorbance capacity was also substantially lower than that of ascorbic acid in the same assay.
Why the distinction is not academic
The category sells THDC on a single adjective. It is the stable vitamin C: oil-soluble, non-irritating, no low pH required, no browning bottle. Most of that is true and useful. The problem is the word doing the work.
A molecule does not have a stability. A molecule has a stability under stated conditions — a given oxygen environment, a given vehicle, a given set of companions in the formula. Move the conditions and the number moves with them. Six minutes to complete degradation, and 75 % surviving at ten minutes, are the same molecule in the same experiment. The difference is what else was in the tube.
| What was measured | THDC alone | THDC with acetyl zingerone |
|---|---|---|
| Degradation under singlet oxygen | complete by 6 minutes | 25 % at 10 minutes |
| Collagen I production | no significant change | increased in combination |
| Type I interferon genes (reconstructed human epidermis) | up-regulated | effect abrogated |
Read as a marketing claim, this is bad news. Read as a formulation specification, it is the opposite: it tells you exactly what the molecule needs in order to do the job it is bought for.
What it changes in practice
Three things follow, and we apply all three.
An ascorbate ester is specified with its antioxidant system, not alone. A concentration on a label — 10 %, 20 %, 30 % of THDC — describes how much went in, not how much is still intact when the product reaches the skin. The accompanying system is not a supporting ingredient; on this evidence it is a condition of the claim.
Generic stability claims are not defensible. "Stable vitamin C" without stated conditions is an assertion the literature does not support, and it is precisely the kind of assertion a generative search engine can now check against the published record. A constraint survives that check. A slogan does not.
The oxidative environment is part of the formula. Anhydrous systems, packaging that excludes air and light, and co-antioxidant selection are not finishing touches applied after the active is chosen. On this evidence they are part of choosing it.
What this study does not say
It is an in vitro study. The degradation work was done under deliberately aggressive oxidative conditions, and the gene expression work in reconstructed human epidermis, not on people. It tested one co-antioxidant, so it does not establish that acetyl zingerone is the only or the best partner for an ascorbate ester. And it does not measure what happens on skin, over weeks, from a finished product.
Those limits are real and we state them rather than let the headline number travel further than the evidence behind it. What the study does establish is narrower and still useful: the stability of this ester is conditional, and the conditions are formulable.
Related reading
- What is topical skin nutrition? — the definition this sits inside, with the constraints and the published figures.
- Lipid-soluble vitamin C and the pH constraint — why L-ascorbic acid needs a pH below its pKa, and what an ester changes.
Scope
This article describes published laboratory findings and a formulation principle. It is not a claim to diagnose, treat, cure or prevent any disease, and it is not a performance claim for any product. In the European Union cosmetic claims are governed by Regulation (EC) No 1223/2009 and its common criteria for claim substantiation; in the United States the cosmetic–drug distinction under the Federal Food, Drug, and Cosmetic Act is triggered by the claim made, not by the ingredient used.
Reference
Swindell, W.R., Randhawa, M., Quijas, G., Bojanowski, K. & Chaudhuri, R.K. (2021). Tetrahexyldecyl Ascorbate (THDC) Degrades Rapidly under Oxidative Stress but Can Be Stabilized by Acetyl Zingerone to Enhance Collagen Production and Antioxidant Effects. International Journal of Molecular Sciences 22(16):8756. DOI: 10.3390/ijms22168756. Open access; every figure quoted here was read in the publisher's text.